EMILY CORK: Open Payments
NPI 1245620236 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,517 in 114 payments from 23 companies in 2025. Trend: 2023 $1,261 · 2024 $2,112 · 2025 $2,517
Food & beverage: $2,517
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 24 | $556 |
| GENZYME CORPORATION | 14 | $356 |
| Regeneron Healthcare Solutions, Inc. | 10 | $276 |
| AstraZeneca Pharmaceuticals LP | 12 | $245 |
| GlaxoSmithKline, LLC. | 10 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Viatris Specialty LLC | 4 | $101 |
| Grifols USA, LLC | 4 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95 |
| Genentech USA, Inc. | 4 | $71 |
Products named: DUPIXENT, Arikayce, TRELEGY ELLIPTA, AIRSUPRA, YUPELRI, Prolastin-C Liquid, BREZTRI, Xolair.
Industry payments across AL — which companies pay providers there.
